Investigating new treatments and vaccines for HIV and TB in Southern and East Africa
Aurum Clinical Trials Unit
This study is looking for people in Southern and East Africa to help test new vaccines and treatments for HIV and tuberculosis, with the hope of finding better ways to prevent and manage these diseases.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Aurum Institute Npc NIH-funded |
| Lab location | 1 site (Parktown, Johannesburg, South Africa) |
| Project ID | NIH-10975949 on NIH RePORTER |
What this research studies
This research focuses on developing new vaccines and treatments for HIV and tuberculosis (TB) in Southern and East Africa, where the burden of these diseases is highest. The Aurum Clinical Trials Unit will conduct clinical trials to evaluate the safety and effectiveness of innovative HIV vaccines and therapeutic approaches. By leveraging a network of experienced clinical research sites in South Africa, Zambia, and Uganda, the research aims to improve prevention strategies and treatment options for individuals at risk of or living with HIV and TB. Patients may have the opportunity to participate in trials that could lead to groundbreaking advancements in managing these conditions.
Who could benefit from this research
Good fit: Ideal candidates for participation include individuals aged 21 and older who are at risk of or living with HIV and TB in Southern and East Africa.
Not a fit: Patients who are not living in Southern or East Africa or those under 21 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of effective vaccines and treatments that significantly reduce the incidence of HIV and TB.
How similar studies have performed: Previous research has shown promise in developing HIV vaccines and treatments, indicating that this approach has the potential for success.
Where this research is happening
Parktown, Johannesburg, South Africa
- Aurum Institute Npc — Parktown, Johannesburg, South Africa (Active)
Researchers
- Principal investigator: Churchyard, Gavin John — Aurum Institute Npc
- Study coordinator: Churchyard, Gavin John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.